KCNH channel regulation by intracellular ligands
KCNH channel regulation by intracellular ligands
批准号:
10581873
负责人:
Tinatin I Brelidze
金额:
$10.54万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-05-01 至 2024-03-31
关键词:
ArrhythmiaBindingC-terminalCardiacCyclic NucleotidesDevelopmentElectrodesElectrophysiology (science)EpilepsyFamilyGoalsIon ChannelKnowledgeLigandsMalignant NeoplasmsMethodsMolecularMolecular Mechanisms of ActionMutagenesisN-terminalPharmacologic SubstancePharmacologyPhysiologicalPropertyRegulationStructural ModelsSurface Plasmon ResonanceX-Ray Crystallographybaseneuronal excitabilitynovelnovel strategiespatch clampscreeningsmall moleculesmall molecule librariestooltumor progressionvoltage clamp
中文摘要
KCNH家族中的离子通道具有多种重要的生理功能,
英文摘要
Ion channels in the KCNH family perform diverse and important physiological functions,
including the regulation of cancer progression, neuronal excitability and cardiac
contraction. KCNH channels contain a Per-Arnt-Sim (PAS) domain in their N-terminal
and cyclic nucleotide-binding homology (CNBH) domain in their C-terminal regions.
These intracellular domains are the key functional domains that are largely responsible
for the distinct properties of KCNH channels that determine their physiological
applications. The goal of this proposal is to identify small molecule ligands that directly
bind to the PAS and CNBH domains and uncover the mechanisms of their action on
KCNH channels. We will identify and functionally characterize KCNH channel ligands
using a novel strategy based on the combination of surface plasmon resonance (SPR)
and electrophysiology as the principal methods. We will first identify small molecule
ligands by screening libraries of small molecules against the PAS and CNBH domains
of KCNH channels with the high-throughput SPR method. We will then determine the
functional effects of the identified small molecule ligands with medium-throughput two-
electrode voltage-clamp method. Finally to uncover molecular mechanisms of action of
the identified ligands we will use a combination of patch-clamp current recordings,
mutagenesis, X-ray crystallography, SPR and structural modeling. These studies will
advance our knowledge of KCNH channel regulation by intracellular ligands and PAS
and CNBH domains, provide pharmacological tools to study physiological contributions
of KCNH channels and will greatly facilitate the development of novel pharmaceutical
agents for treatment of cardiac arrhythmias, cancer and epilepsy.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
N- and C-terminal interactions in KCNH channels: The spotlight on the intrinsic ligand.
KCNH 通道中 N 端和 C 端相互作用:内在配体的焦点。
DOI:
10.1085/jgp.201812313
发表时间:
2019
期刊:
The Journal of general physiology
影响因子:
--
作者:
[Brelidze,TinatinI]
通讯作者:
Brelidze,TinatinI
Identification of undecylenic acid as EAG channel inhibitor using surface plasmon resonance-based screen of KCNH channels.
使用基于表面等离振子共振的 KCNH 通道筛选鉴定十一碳烯酸作为 EAG 通道抑制剂。
DOI:
10.1186/s40360-019-0324-8
发表时间:
2019
期刊:
BMC pharmacology & toxicology
影响因子:
2.9
作者:
[Wang,Ze-Jun, Tiwari,PurushottamB, Üren,Aykut, Brelidze,TinatinI]
通讯作者:
Brelidze,TinatinI
Chlorpromazine binding to the PAS domains uncovers the effect of ligand modulation on EAG channel activity.
氯丙嗪与 PAS 结构域的结合揭示了配体调节对 EAG 通道活性的影响。
DOI:
10.1074/jbc.ra119.012377
发表时间:
2020
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Wang,Ze-Jun, Soohoo,StephanieM, Tiwari,PurushottamB, Piszczek,Grzegorz, Brelidze,TinatinI]
通讯作者:
Brelidze,TinatinI
The HCN domain is required for HCN channel cell-surface expression and couples voltage- and cAMP-dependent gating mechanisms.
HCN 结构域是 HCN 通道细胞表面表达所必需的,并耦合电压和 cAMP 依赖性门控机制。
DOI:
10.1074/jbc.ra120.013281
发表时间:
2020
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Wang,Ze-Jun, Blanco,Ismary, Hayoz,Sebastien, Brelidze,TinatinI]
通讯作者:
Brelidze,TinatinI
Functional mechanisms and therapeutic potential of EAG channel regulators
-
批准号:10393686
-
项目类别:
-
资助金额:$51.55万
-
财政年份:2021
-
负责人:Tinatin I Brelidze
-
依托单位:
Functional mechanisms and therapeutic potential of EAG channel regulators
-
批准号:10231407
-
项目类别:
-
资助金额:$54.24万
-
财政年份:2021
-
负责人:Tinatin I Brelidze
-
依托单位:
Functional mechanisms and therapeutic potential of EAG channel regulators
-
批准号:10593928
-
项目类别:
-
资助金额:$60.31万
-
财政年份:2021
-
负责人:Tinatin I Brelidze
-
依托单位:
KCNH channel regulation by intracellular ligands
-
批准号:10372601
-
项目类别:
-
资助金额:$5.63万
-
财政年份:2018
-
负责人:Tinatin I Brelidze
-
依托单位:
KCNH channel regulation by intracellular ligands
-
批准号:10375400
-
项目类别:
-
资助金额:$30.61万
-
财政年份:2018
-
负责人:Tinatin I Brelidze
-
依托单位:
KCNH channel regulation by intracellular ligands
-
批准号:9896844
-
项目类别:
-
资助金额:$30.86万
-
财政年份:2018
-
负责人:Tinatin I Brelidze
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: